CX3CL1 and ovarian carcinoma: Taken together, we show in the present study that CX3CL1, despite activating the adaptive anti-tumour response in ovarian cancer, has an overall tumour-promoting function, which is due in particular to the peculiarities of the intraperitoneal milieu.